Novel Technologies for Vaccine Development

This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharm...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Lukashevich, Igor S. (Επιμελητής έκδοσης), Shirwan, Haval (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Vienna : Springer Vienna : Imprint: Springer, 2014.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03344nam a22004815i 4500
001 978-3-7091-1818-4
003 DE-He213
005 20150519174605.0
007 cr nn 008mamaa
008 141113s2014 au | s |||| 0|eng d
020 |a 9783709118184  |9 978-3-7091-1818-4 
024 7 |a 10.1007/978-3-7091-1818-4  |2 doi 
040 |d GrThAP 
050 4 |a RM281 
050 4 |a QR189-189.5 
072 7 |a MJCM  |2 bicssc 
072 7 |a MED044000  |2 bisacsh 
082 0 4 |a 615.372  |2 23 
245 1 0 |a Novel Technologies for Vaccine Development  |h [electronic resource] /  |c edited by Igor S Lukashevich, Haval Shirwan. 
264 1 |a Vienna :  |b Springer Vienna :  |b Imprint: Springer,  |c 2014. 
300 |a XIV, 386 p. 35 illus., 33 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Reverse Genetics Approaches for Rational Design of Inactivated and Live-Attenuated Influenza Vaccines -- Viral-Vectored Vaccines to Control Pathogenic Filoviruses -- Alphavirus Replicon Vectors for Prophylactic Applications and Cancer Intervention -- Current Status and Future of Polio Vaccines and Vaccination -- Current Status of Hantavirus Vaccines Development -- Experimental DNA-Launched Live Attenuated Vaccines against Infections Caused by Flavi- and Alphaviruses -- Sugar-Based Immune Adjuvants for Use in Recombinant, Viral, Vector, DNA and Other Styles of Vaccines -- Adenovirus-based Vectors for the Development of Prophylactic and Therapeutic Vaccines -- Radiovirotherapy for the Treatment of Cancer -- TRICOM Poxviral-Based Vaccines for the Treatment of Cancer -- The Use of Oncolytic Herpesvirus for the Treatment of Cancer -- SA-4-1BBL; A Novel form of the 4-1BB Costimulatory Ligand as an Adjuvant Platform for the Development of Subunit Cancer Vaccines. 
520 |a This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a “must read” for all those involved in vaccine development, both in academia and industrial vaccine development. 
650 0 |a Medicine. 
650 0 |a Immunology. 
650 0 |a Vaccines. 
650 0 |a Pharmaceutical technology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Vaccine. 
650 2 4 |a Pharmaceutical Sciences/Technology. 
650 2 4 |a Immunology. 
700 1 |a Lukashevich, Igor S.  |e editor. 
700 1 |a Shirwan, Haval.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783709118177 
856 4 0 |u http://dx.doi.org/10.1007/978-3-7091-1818-4  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)